Yes, starting Zoloft (sertraline) can cause visual disturbances including blurred vision
Sertraline is associated with visual disturbances as a recognized adverse effect, with blurred vision being among the most commonly reported ocular side effects. According to the FDA drug label, angle-closure glaucoma is a serious concern that can present with eye pain, changes in vision, or swelling/redness around the eye 1.
Common Visual Side Effects
The most frequently reported visual disturbances with sertraline include:
- Blurred vision/reduced visual acuity - the most common visual complaint 2, 3
- Mydriasis (pupil dilation) - which can occur early in treatment 4
- Angle-closure glaucoma - a serious but less common complication requiring immediate attention 1
According to clinical practice guidelines, SSRIs including sertraline commonly cause dizziness as an adverse effect within the first few weeks of treatment 4. While the guidelines don't specifically list "blurred vision" in their adverse effect profiles, real-world data demonstrates this is a significant concern.
Evidence from Real-World Data
Recent pharmacovigilance analysis of FDA adverse event reports found that SSRIs are significantly associated with eye disorders, with vision blurred being the most commonly reported visual problem 3. A 2022 study analyzing patient reports identified 124 cases of visual problems linked to serotonin reuptake inhibiting antidepressants, with vision blurred/reduced visual acuity reported in 63.7% of cases 2.
Timing and Clinical Significance
Visual disturbances typically emerge:
- Within the first 30 days of treatment in most cases 3
- During the initial weeks when other common side effects also appear 4
Importantly, some patients report that visual problems can be persistent even after discontinuation - 49 patients in one study reported enduring vision problems after stopping treatment 2.
Serious Visual Complications to Monitor
Angle-closure glaucoma is the most serious visual complication and requires immediate evaluation. The FDA label explicitly warns about this risk 1. Patients should be instructed to seek immediate care if they develop:
- Eye pain
- Changes in vision
- Swelling or redness in or around the eye
The FDA recommends that patients at risk undergo eye examination before starting treatment 1.
Other Reported Visual Disturbances
Beyond blurred vision, case reports and observational data document:
- Diplopia (double vision) - documented in case reports 5
- Optic nerve dysfunction with papilledema in rare cases 6
- Night blindness, vitreous floaters, photophobia, and visual field defects 2
Clinical Recommendations
When prescribing sertraline:
- Inform patients that visual disturbances including blurred vision can occur, particularly in the first month
- Screen for narrow-angle glaucoma risk before initiating treatment 1
- Instruct patients to report immediately any eye pain, vision changes, or eye redness/swelling
- Consider dose relationship - while most visual effects occur at therapeutic doses, higher doses may increase risk 3
The guidelines emphasize that most adverse effects of SSRIs emerge within the first few weeks of treatment 4, and this timing applies to visual disturbances as well 3.
Important Caveat
While visual disturbances are documented, they should be distinguished from the more serious psychiatric symptoms that require urgent attention, such as behavioral activation, suicidal ideation, or serotonin syndrome 4. Visual symptoms warrant evaluation but are generally not life-threatening unless they represent angle-closure glaucoma.